Vagistat-1 (tioconazole) ointment is now approved for OTC use

April 1997

Vagistat-1 (tioconazole) ointment is now approved for OTC use. It's the first SINGLE-dose OTC treatment for vaginal yeast infections.

Vagistat-1 is comparable to using Terazol 3 (terconazole) or Monistat 7 (miconazole).

Tioconazole levels persist for 3 to 5 days after one dose.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

IMPROVING QUALITY
Cardiology New drug for hypertension, Diovan (valsartan)
Cardiology Using Cozaar (losartan) for heart failure
Cardiology Whether digoxin really is useful for patients with heart failure
Interactions Drugs that interact with grapefruit
Dermatology Retin-A Micro, a new tretinoin gel for acne
Dermatology Proscar (finasteride) stimulating hair growth
Infectious Diseases Monurol (fosfomycin), a SINGLE dose antibiotic for bladder infections
Infectious Diseases Zagam (sparfloxacin), a new quinolone antibiotic
Infectious Diseases Sporanox (itraconazole) ORAL SOLUTION
Infectious Diseases Viracept (nelfinavir) for treating HIV in both children and adults
Osteoporosis Fosamax (alendronate) to be promoted to PREVENT osteoporosis
Osteoporosis New drug to inhibit bone loss called Skelid (SKEL-id, tiludronate)
Anticoagulants First HOME monitor for patients on warfarin (Coumadin)
Women's Health New estrogen patches will be hitting the market
Women's Health Vagistat-1 (tioconazole) ointment is now approved for OTC use
Asthma New asthma guidelines
Asthma Too many asthmatics still AREN'T using inhaled steroids
Cholesterol Cholestin, a new dietary supplement to lower cholesterol